5 Best Undervalued Stocks To Buy In May 2024 [Forbes]
Royalty Pharma plc - Class A Ordinary Shares (RPRX)
US:NASDAQ Investor Relations:
ir.reprosrx.com/investor-relations
Company Research
Source: Forbes
Those behaviors are best suited for the investor who is mildly risk averse, has a long timeline and prioritizes good fundamentals over stock market trends. If that sounds like you, let's explore the value investing strategy together. We'll review what makes a stock undervalued, outline a screening process for finding value stocks and meet five interesting stock picks that arose from our methodology. What Makes A Stock Undervalued? A stock is undervalued when its price in the market is lower than it should be, given the company's potential. This scenario can arise from various circumstances, including: Internal issues. Execution errors, operational inefficiencies and poor strategic decision-making that affect a company's financial performance will negatively impact investor perception. Investor demand can wane, which puts downward pressure on the stock price. A lower stock price may be justified as long as the issues remain unresolved. Unfortunately for the company, negative inves
Show less
Read more
Impact Snapshot
Event Time:
RPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RPRX alerts
High impacting Royalty Pharma plc - Class A Ordinary Shares news events
Weekly update
A roundup of the hottest topics
RPRX
News
- Agios (AGIO) Up 23% on Selling Brain Cancer Drug Royalty [Yahoo! Finance]Yahoo! Finance
- Agios in pact with Royalty Pharma for brain tumor candidate [Seeking Alpha]Seeking Alpha
- Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million [Yahoo! Finance]Yahoo! Finance
- Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 MillionGlobeNewswire
- Why Cytokinetics (CYTK) Stock Price Was Down 17% on Thursday [Yahoo! Finance]Yahoo! Finance
RPRX
Sec Filings
- 5/29/24 - Form 8-K
- 5/16/24 - Form 4
- 5/9/24 - Form 10-Q
- RPRX's page on the SEC website